These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


324 related items for PubMed ID: 8547653

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
    Ergin M, Denning MF, Izban KF, Amin HM, Martinez RL, Saeed S, Alkan S.
    Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC.
    Ann Oncol; 1997 Sep; 8 Suppl 2():59-63. PubMed ID: 9209643
    [Abstract] [Full Text] [Related]

  • 27. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma.
    Wlodarska I, De Wolf-Peeters C, Falini B, Verhoef G, Morris SW, Hagemeijer A, Van den Berghe H.
    Blood; 1998 Oct 15; 92(8):2688-95. PubMed ID: 9763551
    [Abstract] [Full Text] [Related]

  • 28. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction.
    Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weisenburger DD, Kossakowska AE, Thorner P.
    Blood; 1995 Jun 15; 85(12):3416-22. PubMed ID: 7780128
    [Abstract] [Full Text] [Related]

  • 29. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
    Colleoni GW, Bridge JA, Garicochea B, Liu J, Filippa DA, Ladanyi M.
    Am J Pathol; 2000 Mar 15; 156(3):781-9. PubMed ID: 10702393
    [Abstract] [Full Text] [Related]

  • 30. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS.
    Leuk Lymphoma; 1998 Mar 15; 29(1-2):93-101. PubMed ID: 9638979
    [Abstract] [Full Text] [Related]

  • 31. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease.
    Xerri L, Parc P, Hassoun J, Birnbaum D.
    J Pathol; 1996 Feb 15; 178(2):128-32. PubMed ID: 8683377
    [Abstract] [Full Text] [Related]

  • 32. The clinicopathological features of anaplastic large cell lymphomas expressing p80NPM/ALK.
    Shiota M, Mori S.
    Leuk Lymphoma; 1996 Sep 15; 23(1-2):25-32. PubMed ID: 9021682
    [Abstract] [Full Text] [Related]

  • 33. Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients.
    Herling M, Rassidakis GZ, Viviani S, Bonfante V, Giardini R, Gianni M, Morris SW, Cabanillas F, Medeiros LJ, Sarris AH.
    Leuk Lymphoma; 2001 Sep 15; 42(5):969-79. PubMed ID: 11697652
    [Abstract] [Full Text] [Related]

  • 34. NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis.
    Trümper L, Daus H, Merz H, von Bonin F, Loftin U, Cochlovius C, Möller P, Feller AC, Pfreundschuh M.
    Ann Oncol; 1997 Sep 15; 8 Suppl 2():83-7. PubMed ID: 9209648
    [Abstract] [Full Text] [Related]

  • 35. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
    Ladanyi M, Cavalchire G.
    Genes Chromosomes Cancer; 1996 Mar 15; 15(3):173-7. PubMed ID: 8721682
    [Abstract] [Full Text] [Related]

  • 36. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
    Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T, Mori S.
    Blood; 1995 Sep 01; 86(5):1954-60. PubMed ID: 7655022
    [Abstract] [Full Text] [Related]

  • 37. Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns.
    Ladanyi M, Cavalchire G.
    Diagn Mol Pathol; 1996 Sep 01; 5(3):154-8. PubMed ID: 8866227
    [Abstract] [Full Text] [Related]

  • 38. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
    Falini B, Bigerna B, Fizzotti M, Pulford K, Pileri SA, Delsol G, Carbone A, Paulli M, Magrini U, Menestrina F, Giardini R, Pilotti S, Mezzelani A, Ugolini B, Billi M, Pucciarini A, Pacini R, Pelicci PG, Flenghi L.
    Am J Pathol; 1998 Sep 01; 153(3):875-86. PubMed ID: 9736036
    [Abstract] [Full Text] [Related]

  • 39. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
    Cataldo KA, Jalal SM, Law ME, Ansell SM, Inwards DJ, Fine M, Arber DA, Pulford KA, Strickler JG.
    Am J Surg Pathol; 1999 Nov 01; 23(11):1386-92. PubMed ID: 10555007
    [Abstract] [Full Text] [Related]

  • 40. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
    Waggott W, Lo YM, Bastard C, Gatter KC, Leroux D, Mason DY, Boultwood J, Wainscoat JS.
    Br J Haematol; 1995 Apr 01; 89(4):905-7. PubMed ID: 7772531
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.